v3.25.2
Consolidated Statements of Cash Flows
₪ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Cash flows from operating activities:      
Net loss $ (39,031) $ (86,636) $ (80,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Finance expenses, net 1,231 13 896
Other expenses 445 192
Financial liabilities recorded as listing expenses 7,648
Finance expenses related to convertible loans and warrants 7,227 5,016
Revaluation of liability to Legacy 267 810
ELOC 1,570
Share listing expenses 12,312
Issuance of shares to consultants 2,420
Depreciation and amortization 2,379 7,637 7,791
Impairment of goodwill and intangible assets 653 15,258 23,356
Change in employee benefit liabilities, net (42) (43) (364)
Change in deferred tax liabilities (37) (39) (1,059)
Cost of share-based payment 2,070 7,115 10,516
Adjustments to the profit or loss items 16,615 57,489 41,136
Changes in asset and liability items:      
Decrease (increase) in trade receivables 1,890 13,242 (1,453)
Decrease (increase) in other assets 665 (4,730) 2,462
Increase (decrease) in trade payables (1,591) (3,436) 544
Decrease (increase) in inventories 1,812 (288)
Change in balances of government grants 70 (824)
Increase in other accounts payable 7,776 7,980 15,216
Changes in asset and liability 8,810 14,044 16,481
Cash paid and received during the year for:      
Interest paid,net (277) (717) (806)
Taxes paid (3,227) (382) (243)
Cash paid and received during the year (3,504) (1,099) (1,049)
Net cash used in operating activities (17,110) (16,202) (23,432)
Cash flows from investing activities:      
Investment in restricted bank deposit (660)
Withdrawal from restricted bank deposit 1,407 3,926
(Investment in) restricted cash (337) (1,493) 140
Change in long-term deposits 177
Purchase of property and equipment (84) (297) (624)
Assets acquisition (5,405)
Credit line to a related party (1,615)
Net cash provided by (used in) investing activities (452) 2,136 (6,549)
Cash flows from financing activities:      
Issuance of ordinary shares,net of issuance expenses 2,379 18,836
Short-term loans,net 1,780
Repayment of lease liabilities (1,017) (1,711) (2,065)
Receipt on account of issuance of shares 2,251
Dividend distribution to non-controlling interests (95)
Exercise of options and warrants 5,146 2,005 1,086
Government grants 77
Receipt of short-term loans 19,815 15,227
Acquisition of non-controlling interest (6,768)
Repayment of short-term loans (4,973) (1,210)
Net cash provided by financing activities 17,176 12,927 20,660
Exchange rate differences on cash and cash equivalents (51) 667 (659)
(decrease) in cash and cash equivalents (437) (472) (9,980)
Cash and cash equivalents at the beginning of the year 3,522 3,994 13,974
Cash and cash equivalents at the end of the year 3,085 3,522 3,994
Non-cash transactions:      
Right-of-use asset and liability 627 (2,516) 1,306
Assets acquisition 4,796
Employee benefit assets and liabilities 168 97 121
Reclassification of deferred issuance cost to equity 1,384 1,717
Dividend distribution to non-controlling interests 369
Reclassification of liability to equity 2,670
Conversion of convertible loans $ 7,876 $ 6,143